BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7895080)

  • 1. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
    Wakabayashi K; Honer WG; Masliah E
    Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies.
    Masliah E; Mallory M; DeTeresa R; Alford M; Hansen L
    Brain Res; 1993 Jul; 617(2):258-66. PubMed ID: 8402154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.
    Samuel W; Alford M; Hofstetter CR; Hansen L
    J Neuropathol Exp Neurol; 1997 May; 56(5):499-508. PubMed ID: 9143263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging.
    Brown DF; Risser RC; Bigio EH; Tripp P; Stiegler A; Welch E; Eagan KP; Hladik CL; White CL
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):955-60. PubMed ID: 9786245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.
    Dickson DW; Schmidt ML; Lee VM; Zhao ML; Yen SH; Trojanowski JQ
    Acta Neuropathol; 1994; 87(3):269-76. PubMed ID: 7912027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic and neuritic alterations during the progression of Alzheimer's disease.
    Masliah E; Mallory M; Hansen L; DeTeresa R; Alford M; Terry R
    Neurosci Lett; 1994 Jun; 174(1):67-72. PubMed ID: 7970158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
    Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
    Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology.
    Mattila PM; Rinne JO; Helenius H; Röyttä M
    Acta Neuropathol; 1999 Aug; 98(2):157-64. PubMed ID: 10442555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant.
    Thorns V; Mallory M; Hansen L; Masliah E
    Acta Neuropathol; 1997 Dec; 94(6):539-48. PubMed ID: 9444355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.
    Samuel W; Galasko D; Masliah E; Hansen LA
    J Neuropathol Exp Neurol; 1996 Jan; 55(1):44-52. PubMed ID: 8558171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
    Hansen LA; Daniel SE; Wilcock GK; Love S
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):653-6. PubMed ID: 9598683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions.
    Cabalka LM; Hyman BT; Goodlett CR; Ritchie TC; Van Hoesen GW
    Neurobiol Aging; 1992; 13(2):283-91. PubMed ID: 1522944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.
    Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J
    Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuritic plaques in the Lewy body variant of Alzheimer disease lack paired helical filaments.
    Samuel W; Crowder R; Hofstetter CR; Hansen L
    Neurosci Lett; 1997 Feb; 223(2):73-6. PubMed ID: 9089676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lewy body variant of Alzheimer disease.
    Hansen LA
    J Neural Transm Suppl; 1997; 51():83-93. PubMed ID: 9470130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD.
    Dickson DW; Ruan D; Crystal H; Mark MH; Davies P; Kress Y; Yen SH
    Neurology; 1991 Sep; 41(9):1402-9. PubMed ID: 1653914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model.
    Samuel W; Masliah E; Hill LR; Butters N; Terry R
    Neurology; 1994 Nov; 44(11):2081-8. PubMed ID: 7969963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism-dementia complex on Guam.
    Goto S; Hirano A
    Acta Neuropathol; 1990; 79(5):545-50. PubMed ID: 2109482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.
    Hansen LA; Masliah E; Quijada-Fawcett S; Rexin D
    Neurosci Lett; 1991 Aug; 129(2):269-72. PubMed ID: 1745407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathological criteria for the diagnosis of Alzheimer's disease.
    Markesbery WR
    Neurobiol Aging; 1997; 18(4 Suppl):S13-9. PubMed ID: 9330980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.